TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting ...
Urinary incontinence is a prevalent issue that is often overlooked but can affect the quality of life as we age. Whether caused by weakened pelvic muscles, hormonal changes, or underlying health ...
OAB is commonly treated with a class of medicines called anticholinergics or antimuscarinics. These medicines block chemicals in your body that help the bladder to squeeze. By blocking these chemicals ...
The Fourth International Consultation on Incontinence recently redefined the signs, symptoms, urodynamic observations and conditions associated with lower urinary tract symptoms and urodynamic studies ...
“Our message is to be careful when using these medicines,” said U.S. Navy neurologist Dr. Jack Tsao, who led the study. “It may be better to use diapers and be able to think clearly than the other way ...
The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a ...
Urinary incontinence or bladder leakage occurs when urine (pee) comes out of your bladder when you do not want it to (involuntarily). It is more common in women for the following reasons: ...
Anticholinergic drugs that act on the central nervous system should be avoided when treating people diagnosed with dementia for incontinence and other bladder conditions, a new study confirms.
*Urinary incontinence impacts over 25 million Americans, yet nearly half of those affected feel too embarrassed to discuss it with their doctor. “People use the word ‘diapers’ with such shame and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results